Within research settings, the combination of TB-500, BPC-157 and GHK-Cu allows investigation of pathways including angiogenesis signalling, connective tissue repair, extracellular matrix remodelling and cellular regeneration processes
Where BPC-157 and TB-500 act primarily through actin/cytoskeletal and growth-factor pathways, GHK-Cu's mechanism is dominated by transcriptional reprogramming via copper-dependent gene regulation, making it a complementary research tool when investigators wish to dissect transcription-driven from structural-protein-driven repair phenotypes
Not licensed for human use in the UK AOD-9604: Not approved for any medical use
Clinical studies confirm efficacy in skin regeneration, and animal data supports systemic anti-aging and tissue repair properties
UK Research suggests they may support nerve repair, enhance cognitive function, and protect against neurodegenerative conditions, though more studies are needed to confirm their efficacy and safety for these purposes